TEAH DOLES-JOHNSON: Open Payments
NPI 1982062758 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 20 payments from 7 companies in 2025. Trend: 2023 $396 · 2024 $1,869 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $80 |
| Tris Pharma Inc | 3 | $69 |
| Almatica Pharma LLC | 3 | $61 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: Jornay PM, Dyanavel XR, LOREEV XR, INGREZZA, CAPLYTA, REXULTI, ABILIFY MAINTENA, UZEDY.
Industry payments across NC — which companies pay providers there.
